Raymond Snyder

Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms

Fionn Woodcock, Brett Doble

Journal article  |  2018  |  Med Decis Making

OBJECTIVES: To assess the external validity of mapping algorithms for predicting EQ-5D-3L utility values from EORTC QLQ-C30 respon..

Exploring the feasibility and utility of exome-scale tumour sequencing in a clinical setting

Belinda Lee, Ben Tran, Arthur L Hsu, Graham R Taylor, Stephen B Fox, Andrew Fellowes, Renata Marquis, Jennifer Mooi, Jayesh Desai, Ken Doig, Paul Ekert, Clara Gaff, Dishan Herath, Anne Hamilton, Paul James, Andrew Roberts, Ray Snyder, Paul Waring, Grant McArthur

Journal article  |  2018  |  Internal Medicine Journal

The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity

Puey Ling Chia, K Chiang, R Snyder, A Dowling

Journal article  |  2018  |  Journal of Oncology Pharmacy Practice

A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollment

Catriona Parker, Raymond Snyder, Michael Jefford, David Dilts, Rory Wolfe, Jeremy Millar

Journal article  |  2017  |  Journal of the National Comprehensive Cancer Network

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.

Harriet Johansson, Kathryn P Gray, Olivia Pagani, Meredith M Regan, Giuseppe Viale, Valentina Aristarco, Debora Macis, Antonella Puccio, Susanne Roux, Rudolf Maibach, Marco Colleoni, Manuela Rabaglio, Karen N Price, Alan S Coates, Richard D Gelber, Aron Goldhirsch, Roswitha Kammler, Bernardo Bonanni, Barbara A Walley, undefined the TEXT principal investigators

Journal article  |  2016  |  Breast Cancer Research

BACKGROUND: Single nucleotide polymorphisms (SNPs) in the estrogen receptor 1 (ESR1) and cytochrome P450 19A1 (CYP19A1) genes have..

Systemic treatment of HER2-positive metastatic breast cancer: A systematic review

Nicholas Wilcken, Nicholas Zdenkowski, Michelle White, Ray Snyder, Ken Pittman, Paul Mainwaring, Michael Green, Prudence Francis, Richard De Boer, Maree Colosimo, Sue Chua, Jacquie Chirgwin, Jane Beith, Richard Bell

Journal article  |  2014  |  Asia-Pacific Journal of Clinical Oncology

Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study

David M Hyams, Arlene Chan, Celia de Oliveira, Raymond Snyder, Jeferson Vinholes, M William Audeh, Victor M Alencar, Janine Lombard, Bijoyesh Mookerjee, John Xu, Kathryn Brown, Paula Klein

Journal article  |  2013  |  INVESTIGATIONAL NEW DRUGS

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node-Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Otto Metzger-Filho, Zhuoxin Sun, Giuseppe Viale, Karen N Price, Diana Crivellari, Raymond D Snyder, Richard D Gelber, Monica Castiglione-Gertsch, Alan S Coates, Aron Goldhirsch, Fatima Cardoso

Journal article  |  2013  |  Journal of Clinical Oncology

A retrospective cohort study of metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy, with an exploratory analysis of changing serum carcinoembryonic antigen levels

Say Liang Ng, William I Burns, Raymond D Snyder, Genni M Newnham, Sue-Anne Mclachlan, Danny Liew, Anthony J Dowling

Journal article  |  2012  |  Asia Pacific Journal of Clinical Oncology

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX

S Aebi, Z Sun, D Braun, KN Price, M Castiglione-Gertsch, M Rabaglio, RD Gelber, D Crivellari, J Lindtner, R Snyder, P Karlsson, E Simoncini, BA Gusterson, G Viale, MM Regan, AS Coates, A Goldhirsch

Journal article  |  2011  |  Annals of Oncology